FDA Approves First Drug to Treat Low Sexual Desire in Women
The American Sexual Health Association strongly supports the Food and Drug Administration’s (FDA) decision to empower women and their healthcare providers by approving Flibanserin, the first drug to treat low sexual desire in females. Hypoactive sexual desire disorder (HSDD, also known as low sexual desire) is the most commonly reported type of sexual dysfunction in […]
August is Immunization Awareness Month
Each August, National Immunization Awareness Month provides an opportunity to highlight the value of immunization across the lifespan. At ASHA, we focus on three important vaccines that can help prevent sexually transmitted infections—vaccines for human papillomavirus (HPV), Hepatitis B and Hepatitis A. HPV HPV is very common. Most sexually active people have HPV at some […]